Cargando…
Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports
Cutaneous adverse events to dupilumab can be varied; this necessitates keeping a broad differential diagnosis to identify seemingly paradoxical reactions. It may be possible to treat the adverse event concurrently without stopping dupilumab.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455398/ https://www.ncbi.nlm.nih.gov/pubmed/32884774 http://dx.doi.org/10.1002/ccr3.2871 |